| Literature DB >> 31040718 |
Yongli Yang1, Zhiwei Cheng2, Xiaocan Jia1, Nian Shi3, Zhenhua Xia1, Weiping Zhang1, Xuezhong Shi1.
Abstract
PURPOSE: The effects of age, period, and cohort on mortality rates of bladder cancer in China remained vague. This study aimed to analyze the secular trends of bladder cancer mortality in China and estimate the independent effects of age, period, and cohort.Entities:
Keywords: age effect; bladder cancer; cohort effect; intrinsic estimator; period effect
Year: 2019 PMID: 31040718 PMCID: PMC6462171 DOI: 10.2147/CMAR.S189220
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Figure 1Trends of ASMRs/100,000 population for bladder cancer in China.
Abbreviation: ASMRs, age-standardized mortality rates.
Figure 2Age, period, and cohort-specific mortality rates for bladder cancer/100,000 population in China.
Note: (A) Shows the bladder cancer mortality of total population; (B) shows the bladder cancer mortality of males; and (C) shows the bladder cancer mortality of females.
APC model analysis of bladder cancer mortality in China by gender
| Total | Males | Females | |
|---|---|---|---|
|
| |||
| Coef. (95% CI) | Coef. (95% CI) | Coef. (95% CI) | |
|
| |||
| Age (year) | |||
|
| |||
| 35–39 | −2.02 (−4.16 to 0.12) | −2.06 (−3.85 to −0.28) | −2.04 (−5.00 to 0.93) |
| 40–44 | −1.68 (−3.3 to −0.06) | −1.80 (−3.20 to −0.41) | −1.41 (−3.43 to 0.61) |
| 45–49 | −1.30 (−2.65 to 0.04) | −1.41 (−2.56 to −0.26) | −1.05 (−2.75 to 0.65) |
| 50–54 | −0.65 (−1.67 to 0.37) | −0.68 (−1.54 to 0.18) | −0.59 (−1.97 to 0.79) |
| 55–59 | −0.20 (−1.01 to 0.61) | −0.23 (−0.91 to 0.46) | −0.17 (−1.26 to 0.92) |
| 60–64 | 0.28 (−0.34 to 0.90) | 0.30 (−0.21 to 0.82) | 0.20 (−0.66 to 1.06) |
| 65–69 | 0.73 (0.26 to 1.21) | 0.80 (0.41 to 1.19) | 0.56 (−0.12 to 1.23) |
| 70–74 | 1.29 (0.89 to 1.69) | 1.35 (1.02 to 1.67) | 1.15 (0.59 to 1.71) |
| 75–79 | 1.64 (1.20 to 2.08) | 1.71 (1.35 to 2.07) | 1.55 (0.95 to 2.15) |
| 80–84 | 1.91 (1.34 to 2.47) | 2.02 (1.56 to 2.49) | 1.81 (1.05 to 2.57) |
|
| |||
| Period (year) | |||
|
| |||
| 1991– | −0.07 (−0.51 to 0.37) | −0.09 (−0.46 to 0.27) | 0.04 (−0.55 to 0.64) |
| 1996– | 0.05 (−0.23 to 0.32) | 0.06 (−0.17 to 0.28) | 0.09 (−0.30 to 0.48) |
| 2001– | −0.11 (−0.33 to 0.12) | −0.18 (−0.37 to 0.00) | −0.04 (−0.37 to 0.30) |
| 2006– | 0.02 (−0.27 to 0.32) | 0.06 (−0.18 to 0.30) | −0.06 (−0.48 to 0.37) |
| 2011–2015 | 0.10 (−0.33 to 0.53) | 0.16 (−0.20 to 0.51) | −0.04 (−0.63 to 0.56) |
|
| |||
| Cohort (year) | |||
|
| |||
| 1911– | 0.96 (0.08 to 1.83) | 1.11 (0.40 to 1.83) | 0.78 (−0.42 to 1.98) |
| 1916– | 0.87 (0.16 to 1.59) | 0.94 (0.36 to 1.53) | 0.79 (−0.19 to 1.77) |
| 1921– | 0.71 (0.08 to 1.33) | 0.73 (0.22 to 1.24) | 0.68 (−0.19 to 1.55) |
| 1926– | 0.68 (0.09 to 1.27) | 0.67 (0.19 to 1.15) | 0.66 (−0.18 to 1.51) |
| 1931– | 0.55 (−0.06 to 1.17) | 0.52 (0.02 to 1.02) | 0.56 (−0.32 to 1.44) |
| 1936– | 0.31 (−0.42 to 1.03) | 0.26 (−0.33 to 0.86) | 0.33 (−0.71 to 1.36) |
| 1941– | 0.09 (−0.8 to 0.97) | 0.05 (−0.67 to 0.78) | 0.11 (−1.15 to 1.36) |
| 1946– | 0.02 (−1.04 to 1.08) | −0.03 (−0.91 to 0.84) | 0.04 (−1.44 to 1.52) |
| 1951– | −0.13 (−1.38 to 1.12) | −0.15 (−1.19 to 0.88) | −0.17 (−1.89 to 1.56) |
| 1956– | −0.36 (−1.81 to 1.1) | −0.39 −1.60 to 0.83) | −0.32 (−2.29 to 1.64) |
| 1961– | −0.52 (−2.31 to 1.26) | −0.52 (−2.00 to 0.96) | −0.56 (−3.02 to 1.9) |
| 1966– | −0.50 (−2.69 to 1.69) | −0.47 (−2.30 to 1.35) | −0.55 (−3.52 to 2.42) |
| 1971– | −1.05 (−4.37 to 2.28) | −1.06 (−3.84 to 1.72) | −0.89 (−5.21 to 3.42) |
| 1976–1980 | −1.62 (−9.26 to 6.01) | −1.66 (−7.90 to 4.59) | −1.46 (−12.24 to 9.33) |
|
| |||
| Intercept | 0.73 (0.04 to 1.42) | 1.15 (0.59 to 1.72) | 0.03 (−0.93 to 0.98) |
| Deviance | 1.34 | 2.50 | 1.06 |
| AIC | 3.91 | 4.29 | 3.31 |
| BIC | −92.55 | −91.39 | −92.83 |
Abbreviations: AIC, Akaike information criterion; BIC, Bayesian information criterion; Coef., coefficient; APC, age-period-cohort.
Figure 3Age, period, and cohort effects on bladder cancer mortality in China and the corresponding 95% CIs.
Note: (A) Shows the bladder cancer mortality of total population; (B) shows the bladder cancer mortality of males; and (C) shows the bladder cancer mortality of females.
Abbreviation: APC, age-period-cohort.